Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Insider Transactions

Date Name Title Type Shares Traded Price Range
May 17, 2018
Director
Director Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 112,500 $1.43
May 17, 2018
Director
Director Other acquisition or disposition -- --
May 17, 2018
Director
Director Bona fide gift 362,926 --
May 17, 2018
Director
Director Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 250,426 $1.47
May 17, 2018
Director
Director Other acquisition or disposition -- --
May 17, 2018
Director
Director Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 250,426 --
May 17, 2018
Director
Director Other acquisition or disposition -- --
May 17, 2018
Director
Director Other acquisition or disposition -- --
May 17, 2018
Director
Director Other acquisition or disposition -- --
May 17, 2018
Director
Director Bona fide gift 362,926 --
May 17, 2018
Director
Director Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 112,500 --
May 14, 2018
Director
Director Open market or private sale of non-derivative or derivative security 9,275 $18.32
May 14, 2018
EVP, COO & CCO
EVP, COO & CCO Open market or private sale of non-derivative or derivative security 3,290 $18.10
May 14, 2018
EVP, COO & CCO
EVP, COO & CCO Other acquisition or disposition -- --
May 10, 2018
Director
Director Open market or private sale of non-derivative or derivative security 30,000 $17.55
May 10, 2018
Director
Director Other acquisition or disposition -- --
May 10, 2018
Director
Director Open market or private sale of non-derivative or derivative security 30,000 $17.13
May 10, 2018
Director
Director Other acquisition or disposition -- --
May 10, 2018
Director
Director Other acquisition or disposition -- --
May 10, 2018
Director
Director Other acquisition or disposition -- --
May 10, 2018
Director
Director Other acquisition or disposition -- --
May 10, 2018
Director
Director Other acquisition or disposition -- --
May 10, 2018
Director
Director Open market or private sale of non-derivative or derivative security 24,014 $18.38
May 07, 2018
Director
Director Other acquisition or disposition -- --
May 07, 2018
Director
Director Other acquisition or disposition -- --

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Copyright West LLC. Minimum 15 minutes delayed.